Literature DB >> 25352311

A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patients.

Toshihiko Sato1, Haruhiko Kondo, Atsushi Watanabe, Jun Nakajima, Hiroshi Niwa, Hirotoshi Horio, Jiro Okami, Norihito Okumura, Kenji Sugio, Satoshi Teramukai, Kazuma Kishi, Masahito Ebina, Yukihiko Sugiyama, Takashi Kondo, Hiroshi Date.   

Abstract

OBJECTIVE: Lung cancer patients with interstitial lung diseases (ILDs) who have undergone pulmonary resection often develop acute exacerbation of interstitial pneumonia (AE) in the post-operative period. To predict who is at high risk of AE, we propose a scoring system that evaluates the risk of AE in lung cancer patients with ILDs.
METHODS: We derived a score for 30-day risk of AE onset after pulmonary resection in lung cancer patients with ILDs (n = 1,022; outcome: risk of AE) based on seven risk factors for AE that were identified in a previous retrospective multi-institutional cohort study. A logistic regression model was employed to develop a risk prediction model for AE.
RESULTS: A risk score (RS) was derived: 5 × (history of AE) + 4 × (surgical procedures) + 4 × (UIP appearance in CT scan) + 3 × (male sex) + 3 × (preoperative steroid use) + 2 × (elevated serum sialylated carbohydrate antigen, KL-6 level) + 1 × (low vital capacity). The RS was shown to be moderately discriminatory with a c-index of 0.709 and accurate with the Hosmer-Lemeshow goodness-of-fit test (p = 0.907). The patients were classified into three groups: low risk (RS: 0-10; predicted probability <0.1; n = 439), intermediate risk (RS: 11-14; predicted probability 0.1-0.25; n = 559), and high risk (RS: 15-22; predicted probability >0.25; n = 24).
CONCLUSION: Although further validation and refinement are needed, the risk score can be used in routine clinical practice to identify high risk individuals and to select proper treatment strategies.

Entities:  

Mesh:

Year:  2014        PMID: 25352311     DOI: 10.1007/s11748-014-0487-6

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  23 in total

1.  Stereotactic body radiation therapy for inoperable early stage lung cancer.

Authors:  Robert Timmerman; Rebecca Paulus; James Galvin; Jeffrey Michalski; William Straube; Jeffrey Bradley; Achilles Fakiris; Andrea Bezjak; Gregory Videtic; David Johnstone; Jack Fowler; Elizabeth Gore; Hak Choy
Journal:  JAMA       Date:  2010-03-17       Impact factor: 56.272

2.  New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6.

Authors:  N Kohno; S Kyoizumi; Y Awaya; H Fukuhara; M Yamakido; M Akiyama
Journal:  Chest       Date:  1989-07       Impact factor: 9.410

3.  Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis.

Authors:  Roland M du Bois; Derek Weycker; Carlo Albera; Williamson Z Bradford; Ulrich Costabel; Alex Kartashov; Lisa Lancaster; Paul W Noble; Ganesh Raghu; Steven A Sahn; Javier Szwarcberg; Michiel Thomeer; Dominique Valeyre; Talmadge E King
Journal:  Am J Respir Crit Care Med       Date:  2011-08-15       Impact factor: 21.405

4.  Acute lung injury and acute respiratory distress syndrome after pulmonary resection.

Authors:  C A Kutlu; E A Williams; T W Evans; U Pastorino; P Goldstraw
Journal:  Ann Thorac Surg       Date:  2000-02       Impact factor: 4.330

5.  Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002.

Authors:  Noriyoshi Sawabata; Hisao Asamura; Tomoyuki Goya; Masaki Mori; Yoichi Nakanishi; Kenji Eguchi; Yoshihiko Koshiishi; Meinoshin Okumura; Etsuo Miyaoka; Yoshitaka Fujii
Journal:  J Thorac Oncol       Date:  2010-09       Impact factor: 15.609

6.  The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer.

Authors:  Hirotsugu Kenmotsu; Tateaki Naito; Madoka Kimura; Akira Ono; Takehito Shukuya; Yukiko Nakamura; Asuka Tsuya; Kyoichi Kaira; Haruyasu Murakami; Toshiaki Takahashi; Masahiro Endo; Nobuyuki Yamamoto
Journal:  J Thorac Oncol       Date:  2011-07       Impact factor: 15.609

7.  Predictive factors for postoperative acute exacerbation of interstitial pneumonia combined with lung cancer.

Authors:  Yasushi Shintani; Mitsunori Ohta; Teruo Iwasaki; Naoki Ikeda; Emiko Tomita; Kunimitsu Kawahara; Yuko Ohno
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-04-18

Review 8.  Clinical course and prediction of survival in idiopathic pulmonary fibrosis.

Authors:  Brett Ley; Harold R Collard; Talmadge E King
Journal:  Am J Respir Crit Care Med       Date:  2010-10-08       Impact factor: 21.405

9.  Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer.

Authors:  Toshihiko Sato; Satoshi Teramukai; Haruhiko Kondo; Atsushi Watanabe; Masahito Ebina; Kazuma Kishi; Yoshitaka Fujii; Tetsuya Mitsudomi; Masahiro Yoshimura; Tomohiro Maniwa; Kenji Suzuki; Kazuhiko Kataoka; Yukihiko Sugiyama; Takashi Kondo; Hiroshi Date
Journal:  J Thorac Cardiovasc Surg       Date:  2013-11-20       Impact factor: 5.209

10.  BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis.

Authors:  Talmadge E King; Jürgen Behr; Kevin K Brown; Roland M du Bois; Lisa Lancaster; Joao A de Andrade; Gerd Stähler; Isabelle Leconte; Sébastien Roux; Ganesh Raghu
Journal:  Am J Respir Crit Care Med       Date:  2007-09-27       Impact factor: 21.405

View more
  24 in total

1.  Postoperative pyothorax a risk factor for acute exacerbation of idiopathic interstitial pneumonia following lung cancer resection.

Authors:  Satoru Kobayashi; Yoko Karube; Morimichi Nishihira; Takashi Inoue; Osamu Araki; Sumiko Maeda; Tetsu Sado; Yuji Matsumura; Masayuki Chida
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-06-08

2.  A risk score to predict postoperative complications after lobectomy in elderly lung cancer patients.

Authors:  Yo Kawaguchi; Jun Hanaoka; Yasuhiko Ohshio; Tomoyuki Igarashi; Yoko Kataoka; Keigo Okamoto; Ryosuke Kaku; Kazuki Hayashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-06-28

Review 3.  Lung cancer and interstitial lung disease: a literature review.

Authors:  Jean-Marc Naccache; Quentin Gibiot; Isabelle Monnet; Martine Antoine; Marie Wislez; Christos Chouaid; Jacques Cadranel
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

4.  Perioperative pirfenidone treatment for lung cancer patients with idiopathic pulmonary fibrosis.

Authors:  Masatoshi Kanayama; Masataka Mori; Hiroki Matsumiya; Akihiro Taira; Shinji Shinohara; Taiji Kuwata; Naoko Imanishi; Kazue Yoneda; Koji Kuroda; Fumihiro Tanaka
Journal:  Surg Today       Date:  2019-11-26       Impact factor: 2.549

5.  What factors determine the survival of patients with an acute exacerbation of interstitial lung disease after lung cancer resection?

Authors:  Masahiro Miyajima; Atsushi Watanabe; Toshihiko Sato; Satoshi Teramukai; Masahito Ebina; Kazuma Kishi; Yukihiko Sugiyama; Haruhiko Kondo; Satoru Kobayashi; Yutaka Takahashi; Hiroyuki Ito; Ryoji Yamamoto; Shigeki Sawada; Hideki Fujimori; Kazunori Okabe; Jun Arikura; Yasushi Shintani; Hiroshige Nakamura; Shinichi Toyooka; Tohru Hasumi; Takehiro Watanabe; Yoshinobu Hata; Hisashi Iwata; Minoru Aoki; Kazuhito Funai; Shuhei Inoue; Osamu Kawashima; Tomohiko Iida; Hiroshi Date
Journal:  Surg Today       Date:  2017-11-09       Impact factor: 2.549

6.  A Simple Prognostic Benefit Scoring System for Sarcoma Patients with Pulmonary Metastases: Sarcoma Lung Metastasis Score.

Authors:  Haruchika Yamamoto; Hiromasa Yamamoto; Junichi Soh; Etsuji Suzuki; Kei Namba; Ken Suzawa; Kentaroh Miyoshi; Shinji Otani; Mikio Okazaki; Seiichiro Sugimoto; Masaomi Yamane; Takashi Yorifuji; Katsuhito Takahashi; Shinichi Toyooka
Journal:  Ann Surg Oncol       Date:  2020-11-24       Impact factor: 5.344

7.  The surgical outcomes of lung cancer combined with interstitial pneumonia: a single-institution report.

Authors:  Daisuke Taniguchi; Naoya Yamasaki; Takuro Miyazaki; Tomoshi Tsuchiya; Keitaro Matsumoto; Go Hatachi; Tomoyuki Kakugawa; Noriho Sakamoto; Hiroshi Mukae; Takeshi Nagayasu
Journal:  Surg Today       Date:  2017-06-06       Impact factor: 2.549

Review 8.  Perioperative management of hepatectomy in patients with interstitial pneumonia: a report of three cases and a literature review.

Authors:  Norio Kubo; Kenichiro Araki; Takahiro Yamanaka; Kouki Hoshino; Norihiro Ishii; Mariko Tsukagoshi; Takamichi Igarashi; Akira Watanabe; Keitaro Hirai; Fumiyoshi Saitoh; Hiroyuki Kuwano; Ken Shirabe
Journal:  Surg Today       Date:  2017-03-01       Impact factor: 2.549

9.  Clinical significance of Charlson comorbidity index as a prognostic parameter for patients with acute or subacute idiopathic interstitial pneumonias and acute exacerbation of collagen vascular diseases-related interstitial pneumonia.

Authors:  Kota Murohashi; Yu Hara; Yusuke Saigusa; Nobuaki Kobayashi; Takashi Sato; Masaki Yamamoto; Makoto Kudo; Takeshi Kaneko
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

10.  Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients.

Authors:  Kakuhiro Yamaguchi; Satoshi Nakao; Hiroshi Iwamoto; Atsushi Kagimoto; Yoshinori Handa; Shinjiro Sakamoto; Yasushi Horimasu; Takeshi Masuda; Takahiro Mimae; Shintaro Miyamoto; Taku Nakashima; Yasuhiro Tsutani; Kazunori Fujitaka; Yoshihiro Miyata; Hironobu Hamada; Morihito Okada; Noboru Hattori
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.